Company Overview
- Headquarters
- 20 Authors Rd, Concord MA
- Website
- delixtherapeutics.com
- Employees
- 39
- Founded in
- 2019
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$10B
Who is Delix Therapeutics
Delix Therapeutics is a United States-based company headquartered in Concord, Massachusetts. Founded as a biotech company, Delix Therapeutics employs approximately 39 people. Delix Therapeutics is pioneering the development of novel, non-hallucinogenic versions of psychedelic compounds. These psychoplastogen compounds offer the potential for therapeutic benefits without the traditional psychedelic experience. Delix's research focuses on advancing these compounds through preclinical and clinical development with the ultimate goal of providing FDA-approved, at-home medicines for mental health treatment. Delix Therapeutics differentiates itself through its unique platform for discovering and developing psychoplastogen compounds. The company leverages modern pharmaceutical development tools to carefully engineer compounds that offer enhanced safety and therapeutic potential. For further information on Delix Therapeutics and its groundbreaking work, please visit www.delixtherapeutics.com.
Company Leadership
Delix Therapeutics Industry Tags
Companies Similar to Delix Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Delix Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 18 | Arizona City, AZ | 1998 | |
| 10M | 9 | San Diego, CA | ||
| 10M | 6 | Campbell, CA | 2011 | |
| 10M | 2 | Torrington, WY | ||
| 10M | 1 | San Diego, CA | 2016 |